UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 452

Sortiert nach

The zinc transporter SLC39A14/ZIP14 controls G-protein coupled receptor-mediated signaling required for systemic growth

PloS one, 2011-03, Vol.6 (3), p.e18059-e18059

2011

Volltextzugriff (PDF)

A novel pathologic marker, indoleamine 2,3-dioxygenase 1, for the cholangiopathy of immune checkpoint inhibitors-induced immune mediated hepatotoxicity as adverse events and the prediction of additional ursodeoxycholic acid treatment

Medical molecular morphology, 2023-06, Vol.56 (2), p.106-115

2023

Volltextzugriff (PDF)

Requirement of Zinc Transporter SLC39A7/ZIP7 for Dermal Development to Fine-Tune Endoplasmic Reticulum Function by Regulating Protein Disulfide Isomerase

Journal of investigative dermatology, 2017-08, Vol.137 (8), p.1682-1691

2017

Volltextzugriff (PDF)

Liver architecture, cell function, and disease

Seminars in immunopathology, 2009-09, Vol.31 (3), p.399-409

2009

Volltextzugriff (PDF)

The ursodeoxycholic acid response score predicts pathological features in primary biliary cholangitis

Hepatology research, 2021-01, Vol.51 (1), p.80-89

2021

Volltextzugriff (PDF)

It is time to change primary biliary cirrhosis (PBC): New nomenclature from "cirrhosis" to "cholangitis", and upcoming treatment based on unveiling pathology

Hepatology research, 2016-04, Vol.46 (5), p.407-415

2016

Volltextzugriff (PDF)

Oxidized Low-Density Lipoprotein Promotes In Vitro Calcification

Materials, 2020-11, Vol.13 (22), p.5120

2020

Volltextzugriff (PDF)

Risk Factors Associated with Stenotrophomonas maltophilia Bacteremia: A Matched Case-Control Study

PloS one, 2015-07, Vol.10 (7), p.e0133731-e0133731

2015

Volltextzugriff (PDF)

Glecaprevir and pibrentasvir for Japanese patients with chronic hepatitis C genotype 1 or 2 infection: Results from a multicenter, real‐world cohort study

Hepatology research, 2019-06, Vol.49 (6), p.617-626

2019

Volltextzugriff (PDF)

Evaluation of Enamel Acid Resistance and Whitening Effect of the CAP System

Dentistry journal, 2022-08, Vol.10 (9), p.161

2022

Volltextzugriff (PDF)

NS5A resistance-associated variants undermine the effectiveness of ledipasvir and sofosbuvir for cirrhotic patients infected with HCV genotype 1b

Journal of gastroenterology, 2017-07, Vol.52 (7), p.845-854

2017

Volltextzugriff (PDF)

Interaction between Toll‐like receptors and natural killer cells in the destruction of bile ducts in primary biliary cirrhosis

Hepatology (Baltimore, Md.), 2011-04, Vol.53 (4), p.1270-1281

2011

Volltextzugriff (PDF)

Hydrophobic bile acids suppress expression of AE2 in biliary epithelial cells and induce bile duct inflammation in primary biliary cholangitis

Journal of autoimmunity, 2016-12, Vol.75, p.150-160

2016

Volltextzugriff (PDF)

Characteristics of Accessory Mental Foramina Observed on Limited Cone-beam Computed Tomography Images

Journal of endodontics, 2008-12, Vol.34 (12), p.1441-1445

2008

Volltextzugriff (PDF)

Significance of immunoglobulin G4 (IgG4)-positive cells in extrahepatic cholangiocarcinoma: Molecular mechanism of IgG4 reaction in cancer tissue

Hepatology (Baltimore, Md.), 2012-07, Vol.56 (1), p.157-164

2012

Volltextzugriff (PDF)

Ledipasvir and sofosbuvir for 12 weeks for hepatitis C virus genotype 2 infection: A propensity score matched analysis

Hepatology research, 2020-02, Vol.50 (2), p.174-181

2020

Volltextzugriff (PDF)

Clinical milestones for the prediction of severe anemia by chronic hepatitis C patients receiving telaprevir-based triple therapy

Journal of hepatology, 2013-10, Vol.59 (4), p.667-674

2013

Volltextzugriff (PDF)

Effects of functional monomers and photo-initiators on the degree of conversion of a dental adhesive

Acta biomaterialia, 2012-05, Vol.8 (5), p.1928-1934

2012

Volltextzugriff (PDF)

CX3CL1 (fractalkine): A signpost for biliary inflammation in primary biliary cirrhosis

Hepatology (Baltimore, Md.), 2010-02, Vol.51 (2), p.567-575

2010

Volltextzugriff (PDF)

Effectiveness and safety of daclatasvir plus asunaprevir for patients with hepatitis C virus genotype 1b aged 75 years and over with or without cirrhosis

Hepatology research, 2017-03, Vol.47 (3), p.E120-E131

2017

Volltextzugriff (PDF)

Diabetes Mellitus Prevents an Improvement in the Serum Albumin Level During Interferon-free Sofosbuvir-based Therapy for Chronic Hepatitis C Patients: A Multi-institutional Joint Study

Internal Medicine, 2018/06/01, Vol.57(11), pp.1533-1542

2018

Volltextzugriff (PDF)

Risk factors for hepatitis B virus recurrence after living donor liver transplantation: A 17-year experience at a single center

Hepatology research, 2015-12, Vol.45 (12), p.1203-1210

2015

Volltextzugriff (PDF)

Critical involvement of ZEB2 in collagen fibrillogenesis: the molecular similarity between Mowat-Wilson syndrome and Ehlers-Danlos syndrome

Scientific reports, 2017-04, Vol.7 (1), p.46565-46565, Article 46565

2017

Volltextzugriff (PDF)

1 – 25 von 452

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(376)
Mit Volltextzugriff
(437)

Publikationsform

Sprache

Englisch
(370)
Japanisch
(177)
Chinesisch
(2)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(255)
Life Sciences & Biomedicine
(231)
Humans
(179)
Female
(98)
Male
(88)
Gastroenterology & Hepatology
(77)
Middle Aged
(73)
Aged
(67)
Adult
(50)
Biological And Medical Sciences
(44)
Medical Sciences
(41)
Animals
(37)
Endocrinology & Metabolism
(35)
Immunology
(34)
Primary Biliary Cirrhosis
(32)
Liver Cirrhosis, Biliary - Immunology
(31)
Hepatitis C Virus
(29)
Liver Cirrhosis
(28)
Medicine
(28)
Treatment Outcome
(27)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Kanzo
(52)
Kanzō/kanzou
(23)
肝臓
(22)
Hepatology Research
(20)
Hepatology
(17)
Internal Medicine
(14)
Journal Of Diabetes Investigation
(14)
Journal Of Cutaneous Immunology And Allergy
(12)
Journal Of Hepatology
(12)
Plos One
(11)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

The zinc transporter SLC39A14/ZIP14 controls G-protein coupled receptor-mediated signaling required for systemic growth

A novel pathologic marker, indoleamine 2,3-dioxygenase 1, for the cholangiopathy of immune checkpoint inhibitors-induced immune mediated hepatotoxicity as adverse events and the prediction of additional ursodeoxycholic acid treatment

Requirement of Zinc Transporter SLC39A7/ZIP7 for Dermal Development to Fine-Tune Endoplasmic Reticulum Function by Regulating Protein Disulfide Isomerase

Liver architecture, cell function, and disease

The ursodeoxycholic acid response score predicts pathological features in primary biliary cholangitis

It is time to change primary biliary cirrhosis (PBC): New nomenclature from "cirrhosis" to "cholangitis", and upcoming treatment based on unveiling pathology

Oxidized Low-Density Lipoprotein Promotes In Vitro Calcification

Risk Factors Associated with Stenotrophomonas maltophilia Bacteremia: A Matched Case-Control Study

Glecaprevir and pibrentasvir for Japanese patients with chronic hepatitis C genotype 1 or 2 infection: Results from a multicenter, real‐world cohort study

Evaluation of Enamel Acid Resistance and Whitening Effect of the CAP System

NS5A resistance-associated variants undermine the effectiveness of ledipasvir and sofosbuvir for cirrhotic patients infected with HCV genotype 1b

Interaction between Toll‐like receptors and natural killer cells in the destruction of bile ducts in primary biliary cirrhosis

Hydrophobic bile acids suppress expression of AE2 in biliary epithelial cells and induce bile duct inflammation in primary biliary cholangitis

Characteristics of Accessory Mental Foramina Observed on Limited Cone-beam Computed Tomography Images

Significance of immunoglobulin G4 (IgG4)-positive cells in extrahepatic cholangiocarcinoma: Molecular mechanism of IgG4 reaction in cancer tissue

Ledipasvir and sofosbuvir for 12 weeks for hepatitis C virus genotype 2 infection: A propensity score matched analysis

Safety, Tolerability, and Preliminary Efficacy of the Anti-Fibrotic Small Molecule PRI-724, a CBP/β-Catenin Inhibitor, in Patients with Hepatitis C Virus-related Cirrhosis: A Single-Center, Open-Label, Dose Escalation Phase 1 Trial

The zinc transporter SLC39A13/ZIP13 is required for connective tissue development; its involvement in BMP/TGF-beta signaling pathways

Clinical milestones for the prediction of severe anemia by chronic hepatitis C patients receiving telaprevir-based triple therapy

Effects of functional monomers and photo-initiators on the degree of conversion of a dental adhesive

CX3CL1 (fractalkine): A signpost for biliary inflammation in primary biliary cirrhosis

Effectiveness and safety of daclatasvir plus asunaprevir for patients with hepatitis C virus genotype 1b aged 75 years and over with or without cirrhosis

Diabetes Mellitus Prevents an Improvement in the Serum Albumin Level During Interferon-free Sofosbuvir-based Therapy for Chronic Hepatitis C Patients: A Multi-institutional Joint Study

Risk factors for hepatitis B virus recurrence after living donor liver transplantation: A 17-year experience at a single center

Critical involvement of ZEB2 in collagen fibrillogenesis: the molecular similarity between Mowat-Wilson syndrome and Ehlers-Danlos syndrome

Suchergebnisse filtern